🇮🇹 TRASTUZUMAB DERUXTECAN in Italy

TRASTUZUMAB DERUXTECAN (TRASTUZUMAB DERUXTECAN) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Enhertu
  • Status: approved

TRASTUZUMAB DERUXTECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB DERUXTECAN approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB DERUXTECAN in Italy?

Marketing authorisation holder not available in our data.